Syndax Pharmaceuticals Inc (SNDX) stock
SNDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$9.45−0.09 (-0.94%)
Close on Nov 13, 2026Market cap $843.86MP/E –Yield –
Syndax Pharmaceuticals operating margin
Operating margin is operating income as a percentage of revenue.
Syndax Pharmaceuticals's operating margin for the twelve months ending Sep 30, 2026 was -61.7%. For fiscal 2025 it was -158.4%, against -1434.4% the year before. The highest annual figure on record is 18.8% in fiscal 2021.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -158.4% | +1276.0 |
| FY2024 | Dec 31, 2024 | -1434.4% | −1453.2 |
| FY2021 | Dec 31, 2021 | 18.8% | +4726.9 |
| FY2020 | Dec 31, 2020 | -4708.2% | −915.2 |
| FY2019 | Dec 31, 2019 | -3792.9% | +1208.8 |
| FY2018 | Dec 31, 2018 | -5001.7% | −2062.7 |
| FY2017 | Dec 31, 2017 | -2939.0% | +648.4 |
| FY2016 | Dec 31, 2016 | -3587.4% | −315.8 |
| FY2015 | Dec 31, 2015 | -3271.6% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -50.3% | +74.9 |
| Q2 FY2026 | Jun 30, 2026 | -54.9% | +127.8 |
| Q1 FY2026 | Mar 31, 2026 | -52.7% | +365.2 |
| Q4 FY2025 | Dec 31, 2025 | -91.0% | +1163.7 |
| Q3 FY2025 | Sep 30, 2025 | -125.2% | +591.4 |
| Q2 FY2025 | Jun 30, 2025 | -182.7% | +1937.7 |
| Q1 FY2025 | Mar 31, 2025 | -417.9% | −493.6 |
| Q4 FY2024 | Dec 31, 2024 | -1254.8% | −1092.9 |
| Q3 FY2024 | Sep 30, 2024 | -716.6% | +5176.3 |
| Q2 FY2024 | Jun 30, 2024 | -2120.5% | +5046.6 |
| Q4 FY2021 | Dec 31, 2021 | 75.6% | +5302.0 |
| Q3 FY2021 | Sep 30, 2021 | -161.9% | +5076.4 |
| Q2 FY2021 | Jun 30, 2021 | -5892.9% | −1510.3 |
| Q1 FY2021 | Mar 31, 2021 | -7167.0% | −3182.8 |
| Q4 FY2020 | Dec 31, 2020 | -5226.3% | −1488.2 |
| Q3 FY2020 | Sep 30, 2020 | -5238.3% | −1768.9 |
| Q2 FY2020 | Jun 30, 2020 | -4382.6% | −326.1 |
| Q1 FY2020 | Mar 31, 2020 | -3984.2% | −76.3 |
| Q4 FY2019 | Dec 31, 2019 | -3738.2% | +1349.5 |
| Q3 FY2019 | Sep 30, 2019 | -3469.4% | +1238.0 |
| Q2 FY2019 | Jun 30, 2019 | -4056.5% | +943.8 |
| Q1 FY2019 | Mar 31, 2019 | -3907.9% | +1303.4 |
| Q4 FY2018 | Dec 31, 2018 | -5087.6% | −3454.0 |
| Q3 FY2018 | Sep 30, 2018 | -4707.4% | +356.9 |
| Q2 FY2018 | Jun 30, 2018 | -5000.3% | −461.9 |
| Q1 FY2018 | Mar 31, 2018 | -5211.3% | −891.0 |
| Q4 FY2017 | Dec 31, 2017 | -1633.6% | +2019.2 |
| Q3 FY2017 | Sep 30, 2017 | -5064.3% | – |
| Q2 FY2017 | Jun 30, 2017 | -4538.4% | – |
| Q1 FY2017 | Mar 31, 2017 | -4320.3% | – |
| Q4 FY2016 | Dec 31, 2016 | -3652.8% | – |
See a number that looks wrong?